India is betting on biopharma to move beyond generics, but gaps in R&D, raw materials, regulation, talent and cold-chain logistics could determine how far the industry goes.

#Biologics #Roche #CentralGovernmentHealthScheme #NIPERs #CDSCO #ASEAN #SHAKTI